The Life Science Spring Summit
Connecting Innovation & Capital.
Key Investor insights
Showcase & Pitch Sessions
SAVE THE DATE // May 26-27 // 2021
biotech pharma diagnostics devices
The Spring Summit 2021
Watch the event online
The BioStock Spring Summit is Virtual
For the first time ever, and of course with all the necessary precautions to keep everyone safe from covid-19, we proudly welcome you to the PREMIER of the annual BioStock Life Science Spring Summit, where innovation and capital connect. Hosted at BioStock's studio at the innovation super-cluster Medicon Village in Lund, the Summit is the Nordic region's premier showcase platform for the region's top early- and growth stage companies covering a number of therapeutic areas.
Here, companies get the opportunity to pitch virtually to industry experts, business developers, financing professionals and investors on every level, all in the convenient and safe setting of a virtual platform.
The BioStock Life Science Spring Summit takes place during two days and features showcases from leading private and listed life science companies. The program also includes panel discussions providing crucial insights on life science investments and capital raising with focus on the Nordic markets.
To sum it all up, The Spring Summit is a conveniently accessible, must-attend online event for all serious investors or startup, early stage- or maturing company executives looking for that competitive edge.
Get ready for two days packed with business opportunities!
Last year in November we succeeded in reaching the main goal of the BioStock Life Science Summit: to bring together life science innovation with investors interested in the Nordic life science scene and potential scientific or commercial partners. During two jam-packed event days, a large number of small to medium-sized Nordic pharma, biotech, medical device and diagnostics companies pitched to an attentive online audience of investors and potential partners. The program also included three panel discussions involving top level stakeholders in the life science ecosystem.
Check out the 2020 panels and presenting companies (click the respective company's name) below.
Showcase presentation Schedule
Tuesday Nov 17th – click company names to watch pitches
Welcome note, BioStock
– Break –
– Lunch Break –
– Break –
Closing note, BioStock
Wednesday Nov 18th – click company names to watch pitches
Welcome note, BioStock
– Break –
– Lunch break –
Closing note, BioStock
In addition to providing a platform for companies to showcase their projects and pitch to investors, the BioStock Life Science Spring Summit is also an educational forum where investors and potential partners can share insights, experiences and strategies. This year's event features panel sessions focusing on investment strategies, financing, business development and partnering, with specific focus on the challenges and opportunities in the "new normal".
Mattias Häggblom – Portfolio Manager, Swedbank Robur Medica
Mikael Svensson – Portfolio Manager Healthcare Select, C Worldwide Asset Management
Claus Johansen – Senior Portfolio Manager, Danske Bank Asset Management
Ingrid Teigland Akay – Managing Partner, Hadean Ventures
Ulrica Bjerke – Portfolio Manager Life Science & CIO, Arctic Aurora Life Science
Anna Gran – Business Development Manager, Novo Nordisk
Ton Berkien – Director Business Development, Amgen
Lubor Gaal – SVP Head of Europe, Locust Walk
In 2019, the annual BioStock Life Science Summit, which successfully debuted in 2018, attracted more than 250 guests during two days in 2019. The Summit is unique in that it not only gives companies a platform to showcase their projects and pitch them to investors. It is also an educational forum for companies looking to raise capital and/or reach a partnership as investors and potential partners share insights, experiences and strategies. The 2019 event also featured a number of thought provoking panel sessions on the subjects of investments, financing and partnering, which can all be viewed below.
A SELECTION OF THE +250 COMPANIES, INVESTORS & FINANCING EXPERTS WHO ATTENDED THE BIOSTOCK LIFE SCIENCE SUMMIT IN 2019:
Clinical Laserthermia Systems
Johnson & Johnson
Swedbank Robur Medica
Danske Bank Asset Management
European Investment Bank
Consensus asset management
ABG Sundal Collier
Erik Penser Bank
DeBere Capital Partners
Investor Insights – in search of the next Nordic unicorn
The first panel discussion at BioStock Life Science Summit 2019 featured representatives from major investors in the Nordics such as Björn Odlander from HealthCap, Ingrid Teigland Akay from Hadean Ventures, Johan Kördel from Lundbeckfonden Ventures, along with biotech entrepreneur Carl Borrebaeck from Lund University.
Investing in Innovations – from discovery to market
The second panel discussion at BioStock Life Science Summit 2019 featured Mattias Häggblom from Swedbank Robur Medica, Daniel Bolanowski from Arctic Aurora LifeScience, and Claus Johansen from Danske Bank Asset Management whom gave their expert insights on what fundmanagers look for before they decide to invest.
(Re)fueling the unique Nordic ecosystem – corporate finance & capital raise insights
Financial advisors Benjamin Nordin from ABG Sundal Collier, Jonas Ljungström from Naventus, Kristofer Krolak from Vator Securities, and Stefan Lundberg from Erik Penser Bank all gave their expert insights on capital raising and corporate finance, including giving advice to early stage companies looking to go public.
Industry insights – Partnering in the Nordic region
BioStock Life Science Summit was also a great opportunity for small pharma and medtech companies to meet and discuss potential partnership deals with Big Pharma. This panel session featured Anna Gran from Johnson & Johnson Innovation, Ralf W. Ackermann from Bayer Pharmaceutical, and Åsa Sjöholm-Timén from AstraZeneca shared their view on what big pharma players are looking for in potential partners.
Key learnings from entering a Big Pharma partnership
The final panel of the Summit event focused on lessons learned from past partnerships. Here, AstraZenca and Bayer were joined by representatives of two companies with partnership experience with the respective pharma giants: OnDosis and Pilloxa, in a panel featuring Jan Børge Jakobsen from Bayer Pharmaceutical, Per Nilsson from Pilloxa, Kay Brickmann from AstraZeneca, and Martin Olovsson from OnDosis, whom all shared their partnering experiences from different perspectives.
What is BioStock?
BioStock is the Nordic region's leading digital news and analytics service focusing exclusively on the life science sector. By webcasting the BioStock Life Science Spring Summit live via our multi-channel media platform and extensive media partner network, the showcase presentations and industry insights will be reaching thousands of professional and retail investors in Sweden as well as internationally.
BioStock's daily news briefings are closely monitored by a majority of life science executives in the Nordic region. To learn more about BioStock, feel free to explore our content at biostock.se.